WilliamReillyPolkinghornMD

Physician

Dr. Polkinghorn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1155 4th Street
Suite 405
San Francisco, CA 94158
Phone+1 917-370-8197

Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2007 - 2012
Massachusetts General HospitalResidency, Pediatrics, 2006 - 2007
Harvard Medical SchoolClass of 2006

PubMed

137 citations
The Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam...
Zachary S. Zumsteg, Daniel E. Spratt, Paul B. Romesser, Xin Pei, Zhigang Zhang
European Urology. 2015-06-01
382 citations
Androgen receptor signaling regulates DNA repair in prostate cancers
William R. Polkinghorn, Joel S. Parker, Man Xia Lee, Elizabeth M. Kass, Daniel E. Spratt
Cancer Discovery. 2013-11-01
109 citations
Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer.
Daniel E. Spratt, Zachary S. Zumsteg, Pirus Ghadjar, Marisa A. Kollmeier, Xin Pei
BJU International. 2014-09-01

‘We Ran Out of Money’: High-Profile Startup Seeking to Connect Patients with Clinical Trials Shuts DownNovember 12th, 2018
Driver's High-Cost Cancer Care Procurement App Shutters Shortly After LaunchNovember 12th, 2018
Driver Launches Its Platform to Connect Cancer Patients to the Best TreatmentsSeptember 9th, 2018
Join now to see all